Biblio print

Tree Display

AceDB Schema

XML Display


Paper(s) concerning Aricept~Donepezil~E2020

53 reference(s) found.
Listing paper details in reverse chronological order.
We are grateful to Keith Bradnam for improvment of this script

    Title: Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients
    Zhang N, Gordon ML
    Ref: Clin Interv Aging, 13:1963, 2018 : PubMed


    Title: Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial
    Homma A, Atarashi H, Kubota N, Nakai K, Takase T
    Ref: J Alzheimers Dis, 52:345, 2016 : PubMed


    Title: Use of donepezil in elderly patients with Alzheimer's disease--a Hawaii based study
    Alagiakrishnan K, Wong W, Blanchette PL
    Ref: Hawaii Med J, 59:57, 2000 : PubMed


    Title: Huprine X is a Novel High-Affinity Inhibitor of Acetylcholinesterase That Is of Interest for Treatment of Alzheimer's Disease
    Camps P, Cusack B, Mallender WD, Achab RE, Morral J, Munoz-Torrero D, Rosenberry TL
    Ref: Molecular Pharmacology, 57:409, 2000 : PubMed


    Title: The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease
    Cummings JL, Donohue JA, Brooks RL
    Ref: American Journal of Geriatry & Psychiatry, 8:134, 2000 : PubMed


    Title: Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease
    Jann MW
    Ref: Pharmacotherapy, 20:1, 2000 : PubMed


    Title: Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors
    Kaur J, Zhang MQ
    Ref: Curr Med Chem, 7:273, 2000 : PubMed


    Title: Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats
    Kosasa T, Kuriya Y, Matsui K, Yamanishi Y
    Ref: European Journal of Pharmacology, 389:173, 2000 : PubMed


    Title: [Pharmacological properties of donepezil hydrochloride (Aricept), a drug for Alzheimer's disease]
    Ogura H, Kosasa T, Araki S, Yamanishi Y
    Ref: Nihon Yakurigaku Zasshi, 115:45, 2000 : PubMed


    Title: Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats
    Ogura H, Kosasa T, Kuriya Y, Yamanishi Y
    Ref: Methods Find Exp Clin Pharmacol, 22:89, 2000 : PubMed


    Title: Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro
    Ogura H, Kosasa T, Kuriya Y, Yamanishi Y
    Ref: Methods Find Exp Clin Pharmacol, 22:609, 2000 : PubMed


    Title: Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors
    Sugimoto H, Iimura Y, Kawakami Y, Yamanishi Y
    Ref: Curr Med Chem, 7:303, 2000 : PubMed


    Title: Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients
    Weiner MF, Martin-Cook K, Foster BM, Saine K, Fontaine CS, Svetlik DA
    Ref: J Clin Psychiatry, 61:487, 2000 : PubMed


    Title: Clinical profile of donepezil in the treatment of Alzheimer's disease
    Doody RS
    Ref: Gerontology, 45:23, 1999 : PubMed


    Title: Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs
    Kryger G, Silman I, Sussman JL
    Ref: Structure, 7:297, 1999 : PubMed


    Title: [Treatment of Alzheimer's disease: acetylcholinesterase inhibitors].
    Lopez-Pousa S, Lombardia Fernandez C
    Ref: Neurologia, 14:180, 1999 : PubMed


    Title: Huperzine-A in capsules and tablets for treating patients with Alzheimer disease
    Xu SS, Cai ZY, Qu ZW, Yang RM, Cai YL, Wang GQ, Su XQ, Zhong XS, Cheng RY and Feng B <2 more author(s)>
    Ref: Zhongguo Yao Li Xue Bao, 20:486, 1999 : PubMed


    Title: Donepezil use in Alzheimer disease
    Barner EL, Gray SL
    Ref: Annals of Pharmacotherapy, 32:70, 1998 : PubMed


    Title: Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities
    Cheng DH, Tang XC
    Ref: Pharmacol Biochem Behav, 60:377, 1998 : PubMed


    Title: Drug and Therapeutics Bulletin defends its stance over donepezil [letter]
    Collier J
    Ref: British Medical Journal, 316:1092, 1998 : PubMed


    Title: Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease
    Costagli C, Galli A
    Ref: Biochemical Pharmacology, 55:1733, 1998 : PubMed


    Title: Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications
    Giacobini E
    Ref: Neurochem Int, 32:413, 1998 : PubMed


    Title: How to cope with Alzheimer's disease?
    Hasegawa K
    Ref: Neurobiology of Aging, 19:S107, 1998 : PubMed


    Title: Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica
    Kryger G, Silman I, Sussman JL
    Ref: Journal de Physiologie Paris, 92:191, 1998 : PubMed


    Title: Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group
    Rogers SL, Doody RS, Mohs RC, Friedhoff LT
    Ref: Archives of Internal Medicine, 158:1021, 1998 : PubMed


    Title: A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
    Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT
    Ref: Neurology, 50:136, 1998 : PubMed


    Title: Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
    Rogers SL, Friedhoff LT
    Ref: European Neuropsychopharmacology, 8:67, 1998 : PubMed


    Title: Aricept-induced nightmares in Alzheimer's disease: 2 case reports [letter]
    Ross JS, Shua-Haim JR
    Ref: J Am Geriatr Soc, 46:119, 1998 : PubMed


    Title: Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells
    Svensson AL, Nordberg A
    Ref: Neuroreport, 9:1519, 1998 : PubMed


    Title: Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation
    Taverni JP, Seliger G, Lichtman SW
    Ref: Brain Injury, 12:77, 1998 : PubMed


    Title: Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine
    Wang T, Tang XC
    Ref: European Journal of Pharmacology, 349:137, 1998 : PubMed


    Title: Absence of central cholinergic deficits in ApoE knockout mice
    Anderson R, Higgins GA
    Ref: Psychopharmacology (Berl), 132:135, 1997 : PubMed


    Title: Advertisements for donepezil. National policy needs to be set for prescribing of this drug
    Boothby H, Zaidi SM, Seth V, Khalaf S, Jameel H, Mahomed S, al Y
    Ref: BMJ, 315:1624, 1997 : PubMed


    Title: Donepezil
    Bryson HM, Benfield P
    Ref: Drugs & Aging, 10:234, 1997 : PubMed


    Title: Donepezil (Aricept) therapy for Alzheimer's disease
    Geldmacher DS
    Ref: Compr Ther, 23:492, 1997 : PubMed


    Title: Advertisements for donepezil (Aricept) in the BMJ. Advertisement suggests an unrealistic improvement in mental status
    Gray S
    Ref: BMJ, 314:1555, 1997 : PubMed


    Title: Advertisements for donepezil. Prices charged for private prescriptions for donepezil show huge variation
    Jones RW, Mann JB, Saunders SA
    Ref: BMJ, 315:1624, 1997 : PubMed


    Title: Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia [published erratum appears in Methods Find Exp Clin Pharmacol 1997 Jun;19(5):364]
    Kojima J, Nakajima K, Ochiai M, Nakayama K
    Ref: Methods Find Exp Clin Pharmacol, 19:245, 1997 : PubMed


    Title: Alzheimer's disease: an overview for the pharmacist
    McGuffey EC
    Ref: J Am Pharm Assoc, 3:347, 1997 : PubMed


    Title: Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys
    Rupniak NM, Tye SJ, Field MJ
    Ref: Psychopharmacology, 131:406, 1997 : PubMed


    Title: Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys
    Tsukada H, Kakiuchi T, Ando I, Ouchi Y
    Ref: Journal of Pharmacology & Experimental Therapeutics, 281:1408, 1997 : PubMed


    Title: Advertisements for donepezil (Aricept) in the BMJ. Local committee has declined to approve NHS hospital prescription of donepezil
    Wagner N
    Ref: BMJ, 314:1555, 1997 : PubMed


    Title: Enhancing cognition in the intellectually intact
    Whitehouse PJ, Juengst E, Mehlman M, Murray TH
    Ref: Hastings Center Report, 27:14, 1997 : PubMed


    Title: Advertisements for donepezil. Review of drug in Drug and Therapeutics Bulletin is uninformed
    Wilkinson D
    Ref: BMJ, 315:1625, 1997 : PubMed


    Title: Huperzine A, a novel promising acetylcholinesterase inhibitor
    Cheng DH, Ren H, Tang XC
    Ref: Neuroreport, 8:97, 1996 : PubMed


    Title: The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]m eth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses
    Inoue A, Kawai T, Wakita M, Iimura Y, Sugimoto H, Kawakami Y
    Ref: Journal of Medicinal Chemistry, 39:4460, 1996 : PubMed


    Title: The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo- Controlled Trial. The Donepezil Study Group
    Rogers SL, Friedhoff LT
    Ref: Dementia, 7:293, 1996 : PubMed


    Title: Direct determination of E2020 enantiomers in plasma by liquid chromatography-mass spectrometry and column-switching techniques
    Matsui K, Oda Y, Ohe H, Tanaka S, Asakawa N
    Ref: Journal of Chromatography A, 694:209, 1995 : PubMed


    Title: Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020)
    Nochi S, Asakawa N, Sato T
    Ref: Biol Pharm Bull, 18:1145, 1995 : PubMed


    Title: Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2- yl)methyl]piperidine hydrochloride and related compounds
    Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K
    Ref: Journal of Medicinal Chemistry, 38:4821, 1995 : PubMed


    Title: Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020
    Galli A, Mori F, Benini L, Cacciarelli N
    Ref: European Journal of Pharmacology, 270:189, 1994 : PubMed


    Title: Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program
    Pang YP, Kozikowski AP
    Ref: J Comput Aided Mol Des, 8:683, 1994 : PubMed


    Title: The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory
    Dawson GR, Iversen SD
    Ref: Behavioural Brain Research, 57:143, 1993 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer